Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830700 · ClinicalTrials.gov registry record · NA
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 223
- Enrollment target
- 1
- Study location
NCT00830700 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Seattle Children's Hospital. The registered enrollment target is 223 participants, below the 344-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00830700, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
- 1
- Study location
Study Summary
While telemental health (TMH) programs are increasing nationally to address the inequity of access to psychiatric services, there are few reports of their efficacy, particularly with children. The current proposal will complete the second stage of our program development. In the first stage, we established the feasibility of a TMH service and its acceptability to families and PCPs. In the second stage of program development we will conduct a randomized clinical trial (RCT) that will determine whether it is possible to use technological advances to: 1) improve clinical outcomes for children with ADHD over outcomes achieved in usual PC; and 2) adhere to an EBT protocol implemented through TMH. Future studies will examine whether other types of complicated psychiatric disorders and EBTs are amenable to delivery via TMH. The overall goal of this study is to determine whether an evidence-based model of care can be faithfully implemented when delivered using TMH to children with ADHD living in rural areas and can improve outcomes over treatment as usual (TAU) in PC. ADHD is an excellent focus for assessment of TMH, as PCPs encounter this disorder frequently, EBT guidelines are available, pharmacotherapy is the core treatment and is easily delivered in PC through videoconferencing, and stabilization may be readily achieved for most youth.
Conditions Studied
Interventions
- OTHER CATMH intervention
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830700
The ClinicalTrials.gov registry entry for NCT00830700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 344-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (35% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 1 intervention - of which CATMH intervention is the first listed.
NCT00830700 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00830700 about?
NCT00830700 is a clinical study titled "Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study". While telemental health (TMH) programs are increasing nationally to address the inequity of access to psychiatric services, there are few reports of their efficacy, particularly with children. The current proposal will complete the second stage of our program development. In the first stage, we esta...
What is the current status of trial NCT00830700?
This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2009-09. Estimated completion is 2013-02.
What conditions does trial NCT00830700 study?
This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.
What interventions are being tested in trial NCT00830700?
The interventions under investigation include: CATMH intervention (OTHER).
Who is sponsoring clinical trial NCT00830700?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00830700 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Disorder With Hyperactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · NA
-
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD
COMPLETED · NA
-
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.